1. Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS, BasarDonatoaba A, Coker AL, Creek KE, Pirisi L (2001) Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res 61: 3837–3843
2. Al-Hazzaa AA, Bowen ID, Birchall MA (2001) P53-independent apoptosis induced by cisplatin with ZD1839 (Iressa™) an EGFR-TK inhibitor in an oral squamous cell carcinoma cell line. Clin Cancer Res 7: S3723
3. Bar-Sagi D, Hall A (2000) Ras and Rho GTPases: a family reunion. Cell 103: 227–238
4. Baselga J (2001) The EGFR as a target for anticancer therapy – focus on cetuximab. Eur J Cancer 37: S16–S22
5. Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J (1997) PD153035, a tyrosine kinase inhibitor, prevents epidermal growth receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 3: 2099–2106